1. Home
  2. Clinical Topics
  3. FDA approves new drug for osteoporosis
Clinical TopicsDrugs and DevicesHealthcare & TechnologyMusculoskeletal/OrthopedicsNewsWeb ExclusivesWomen's Health

FDA approves new drug for osteoporosis

Share

On June 1, the U.S. Food and Drug Administration (FDA) approved Prolia (denosumab), an injectable treatment for postmenopausal women with osteoporosis who are at high risk of fractures.

Read more here.

Leave a Reply

Your email address will not be published.

Fill out this field
Fill out this field
Please enter a valid email address.

Get your free subscription to NurseLine!

NurseLine Newsletter

  • Hidden

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.

Recent Posts